BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Kevin J. Cady of OnPoint Vision provides an update on the AccuraSee intraocular pseudophakic contact lens.
The idea behind the lens is to fine-tune refractive error in patients who have already undergone cataract surgery, but the first-generation model addresses age-related macular degeneration, with the company entering into a phase 1 trial.
“The outcomes are looking promising,” Cady said. “We are gaining five to six lines of vision for patients, essentially, you could categorize as going blind. Patients